De Novo device
Minder® System
Epi-Minder Pty, Ltd. · Sub-Scalp Implanted Electroencephalogram System For Remote Patient Monitoring (SEM, Class II) · First FDA decision Apr 17, 2025, newest Oct 29, 2026Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
Breakthrough-designated
Device trials
2
Naming "Minder"
MAUDE reports
0
Brand "Minder", since 2015
PubMed studies
46
Mentioning "Minder"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Minder® System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Minder® System510(k)
K262318 · Decided Oct 29, 2026 · 113 days after receipt
Device type: Sub-Scalp Implanted Electroencephalogram System For Remote Patient Monitoring (SEM) · Neurology & Neurosurgery
- Minder SystemNew device typeBreakthroughDe Novo
DEN240062 · Decided Apr 17, 2025 · 181 days after receipt
Device type: Sub-Scalp Implanted Electroencephalogram System For Remote Patient Monitoring (SEM) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Minder", any status and sponsor, newest update first.
- Diagnosing Epilepsy To EffeCT ChangePivotal-lookingRecruiting
Epiminder America, Inc.Not on our public-company list
NCT07110337 · 210 participants (planned) · Start Dec 23, 2025 · Primary completion Jun 2027
Device: Receipt of the Minder System (implantable sub-scalp continuous electroencephalographic (EEG) monitoring (iCEM) system) · For: Epilepsy; Epilepsy (Treatment Refractory)
Sites: Birmingham, Alabama; Phoenix, Arizona; Irvine, California · 23 sites in all
Epiminder America, Inc.Not on our public-company list
NCT07110454 · 210 participants (planned) · Start Dec 23, 2025 · Primary completion Jan 2029
Device: Previous receipt of the Minder System (implantable continuous electroencephalographic (EEG) monitoring (iCEM) system) · For: Epilepsy; Epilepsy (Treatment Refractory)
Sites: Birmingham, Alabama; Phoenix, Arizona; Palo Alto, California · 21 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Minder", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SEM
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Minder"[tiab]. The summary above synthesizes these.
- Cough and you'll miss it.
Molloy S, Batchelor G, McCadden L, et al. · Arch Dis Child Educ Pract Ed · 2021Case Reports
- Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Vereschagin M, Wang AY, Richardson CG, et al. · J Med Internet Res · 2024Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Evaluating the Effectiveness of a Codeveloped e-Mental Health Intervention for University Students: Protocol for a Randomized Controlled Trial.
Wang AY, Vereschagin M, Richardson CG, et al. · JMIR Res Protoc · 2023
- Sub-scalp electroencephalography: A next-generation technique to study human neurophysiology.
Haneef Z, Yang K, Sheth SA, et al. · Clin Neurophysiol · 2022Review, Research Support, Non-U.S. Gov't
- The UMPIRE study: A first-in-human multicenter trial of bilateral subscalp monitoring for epileptic seizure detection.
Halliday AJ, Gillinder L, Lai A, et al. · Epilepsia · 2025Multicenter Study
- Examining the effects of engagement with an app-based mental health intervention: a secondary analysis of a randomized control trial with treatment non-compliance.
Y Wang A, Vereschagin M, G Richardson C, et al. · Int J Ment Health Syst · 2025
- Lessons Learned From Provider Minder: A Provider Tracking Application for Improving Stroke Risk Screening in Sickle Cell Anemia.
Schlenz AM, Phillips SM, Stevens J, et al. · Qual Manag Health Care · 2026Research Support, U.S. Gov't, P.H.S.
- A Pilot Study Assessing Common Medication Organizers for Child-Resistant Features.
Teum L, Gokhman F, Park S, et al. · AJPM Focus · 2024
- Performance of Repaired Concrete under Cyclic Flexural Loading.
Wang B, Gupta R · Materials (Basel) · 2021
- A visual reminder chart to improve tuberculosis treatment adherence and self-management in a low-resource setting.
Wilandika A, Rahmawati EY, Yusof S, et al. · J Public Health (Oxf) · 2026Research Support, Non-U.S. Gov't
- Seizure Forecasting Using a Novel Sub-Scalp Ultra-Long Term EEG Monitoring System.
Stirling RE, Maturana MI, Karoly PJ, et al. · Front Neurol · 2021
- Using home monitoring technology to study the effects of traumatic brain injury on older multimorbid adults: protocol for a feasibility study.
Parkinson ME, Dani M, Fertleman M, et al. · BMJ Open · 2023Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code SEM.
- UNEEG EpiSight SystemUneeg Medical A/S · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.